State MI
Clinical Trials in Michigan
Michigan is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Michigan and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 319 actively recruiting studies with Michigan sites out of 319 registered in total. The busiest research areas in Michigan are Prostate Cancer, Advanced Solid Tumor, Solid Tumors. Leading sponsors running trials in the state include University of Michigan, University of Michigan Rogel Cancer Center, National Cancer Institute (NCI). By stage, Michigan trials break down as Phase 1 (57), Phase 2 (97), Phase 3 (88), Phase 4 (10).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Michigan
Frequently Asked Questions — Clinical Trials in Michigan
How many clinical trials are currently recruiting in Michigan?
ClinicalMetric currently tracks 319 actively recruiting clinical trials with at least one location in Michigan. The total number of registered studies—including active but not currently enrolling trials—is 319. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Michigan?
Michigan hosts clinical trials across a broad range of medical conditions, including Prostate Cancer, Advanced Solid Tumor, Solid Tumors, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Michigan serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Michigan?
To join a clinical trial in Michigan, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Michigan maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Michigan
NCT06296394 N/A
Recruiting
Health Outcomes of Parents With Cystic Fibrosis-Aim 2
Condition
Cystic Fibrosis
Enrollment
146 pts
Location
United States
Sponsor
University of Pittsburgh
NCT06883305 Phase 3
Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participa...
Condition
Chronic Obstructive Pulmonary Disease (COPD)
Enrollment
990 pts
Location
United States, Brazil, Canada
Sponsor
AstraZeneca
NCT06283966 Phase 3
Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fum...
Condition
COPD (Chronic Obstructive Pulmonary Disease)
Enrollment
5,250 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT07201922 Phase 3
Recruiting
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in ...
Condition
Familial Pulmonary Fibrosis
Enrollment
80 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
NCT05038332 Phase 2
Recruiting
Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Al...
Condition
Prostate Cancer
Enrollment
136 pts
Location
United States
Sponsor
University of Michigan Rogel C
NCT07221500 Phase 2
Recruiting
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyr...
Condition
Chronic Lymphocytic Leukemia (CLL)
Enrollment
100 pts
Location
United States, France, Italy
Sponsor
Nurix Therapeutics, Inc.
NCT05490472 Phase 1, Phase 2
Recruiting
JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
Condition
Solid Tumors
Enrollment
102 pts
Location
United States, China
Sponsor
Jacobio Pharmaceuticals Co., L
NCT06423911 Phase 3
Recruiting
Study of Olverembatinib (HQP1351) in Patients With CML-CP
Condition
Chronic Myeloid Leukemia
Enrollment
333 pts
Location
United States, Australia, Belgium
Sponsor
Ascentage Pharma Group Inc.
NCT06911632 N/A
Recruiting
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring ...
Condition
Pulmonary Hypertension
Enrollment
900 pts
Location
United States
Sponsor
Tempus AI
NCT06506344 N/A
Recruiting
Syncing Screening and Services for Suicide Prevention Across Health and Jail Sys...
Condition
Suicide Prevention
Enrollment
5,250 pts
Location
United States
Sponsor
Henry Ford Health System
NCT05034432 Phase 4
Recruiting
The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventri...
Condition
Arrythmia
Enrollment
100 pts
Location
United States
Sponsor
University of Rochester
NCT06909214 Phase 4
Recruiting
A Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With...
Condition
New Onset Generalized Myasthenia Gravis (gMG)
Enrollment
30 pts
Location
United States
Sponsor
argenx
NCT06585410 Phase 3
Recruiting
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous S...
Condition
Cutaneous Squamous Cell Carcinoma (CSCC)
Enrollment
369 pts
Location
United States, Australia
Sponsor
Regeneron Pharmaceuticals
NCT05733832 N/A
Recruiting
A Trial of Post-Discharge Transitional Care for Patients With Chronic Liver Dise...
Condition
Liver Diseases
Enrollment
1,000 pts
Location
United States
Sponsor
Indiana University
NCT05550298 N/A
Recruiting
Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infectio...
Condition
Hematopoietic Cell Transplant
Enrollment
2,000 pts
Location
United States
Sponsor
Arkansas Children's Hospital R
NCT05204888 N/A
Recruiting
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
Condition
COPD
Enrollment
642 pts
Location
United States, Canada
Sponsor
Temple University
NCT03719105 EARLY_Phase 1
Recruiting
Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Ly...
Condition
NK-Cell Lymphoma
Enrollment
40 pts
Location
United States
Sponsor
New York Medical College
NCT05786924 Phase 1, Phase 2
Recruiting
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Condition
Non-small Cell Lung Cancer
Enrollment
554 pts
Location
United States, Australia, China
Sponsor
Institut de Recherches Interna
NCT06828770 N/A
Recruiting
Minima Stent System Post- Approval Study (PAS)
Condition
Pulmonary Artery Stenosis
Enrollment
100 pts
Location
United States
Sponsor
Renata Medical
NCT04181060 Phase 3
Recruiting
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With E...
Condition
Advanced Lung Non-Squamous Non-Small Cell Carcinoma
Enrollment
300 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT05076942 Phase 2
Recruiting
Groningen International Study on Sentinel Nodes in Vulvar Cancer-III
Condition
Vulvar Cancer
Enrollment
157 pts
Location
United States, Netherlands
Sponsor
University Medical Center Gron
NCT07118202 N/A
Recruiting
TheraBionic P1 Device in Subjects With Advanced Hepatocellular Carcinoma
Condition
Hepatocellular Carcinoma Recurrent
Enrollment
198 pts
Location
United States
Sponsor
Barbara Ann Karmanos Cancer In
NCT06953960 Phase 1, Phase 2
Recruiting
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoc...
Condition
Multiple Myeloma
Enrollment
325 pts
Location
United States, Australia, Belgium
Sponsor
AbbVie
NCT06136559 Phase 3
Recruiting
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of I...
Condition
Chronic Lymphocytic Leukemia
Enrollment
1,200 pts
Location
United States, Australia, Belgium
Sponsor
Merck Sharp & Dohme LLC
NCT04939051 Phase 2
Recruiting
Obeticholic Acid for Prevention in Barrett's Esophagus
Condition
Barrett Esophagus
Enrollment
30 pts
Location
United States
Sponsor
National Cancer Institute (NCI
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology